文献速递脑血管病神经重症与神经感染

急性缺血性卒中患者从入院至血管内取栓的时间与患者报告结局的关系

Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke.
PubMed 文献 · JAMA Neurol · 2024-01-01

该研究基于ESCAPE-NA1随机临床试验数据,纳入1039例接受血管内取栓的大血管闭塞性缺血性卒中患者,分析从入院至动脉穿刺时间与90天EQ-5D-5L指数评分等患者报告结局的关联。结果显示,每提前15分钟治疗,EQ-5D-5L指数评分提高0.03(95%CI 0.02-0.04),EQ-VAS提高1.65(95%CI 0.56-2.72),各领域无或轻微问题的概率增加1.86%至3.55%。

要点

  • 入院至穿刺时间每提前15分钟,90天EQ-5D-5L指数评分提高0.03(95%CI 0.02-0.04)。
  • 入院至穿刺时间小于60分钟与各领域无或轻微问题几率更高相关,OR范围1.49至2.59。
  • 需治疗人数范围为7至17,支持优化院内流程以改善患者报告结局。

核心结论

  • 更快的入院至穿刺血管内取栓时间与所有领域更好的健康相关生活质量强烈相关。
  • 这些结果支持入院至治疗速度对患者报告结局的有益影响,应鼓励通过优化院内流程和工作流程来改善以患者为中心的急性卒中照护。

研究设计与样本

  • 研究数据来自ESCAPE-NA1试验,该试验为国际随机临床试验,于2017年3月1日至2019年8月12日从7个国家招募患者。
  • 纳入90天时具有EQ-5D-5L指数值的患者,最终分析纳入1039例(平均[SD]年龄69.0[13.7]岁;527例男性[50.7%]),其中4例未接受血管内取栓。
  • 896例存活者具有90天完整领域评分;数据分析时间为2023年7月至9月。

主要发现

  • 入院至穿刺时间每提前15分钟,EQ-5D-5L指数评分增加0.03(95%CI 0.02-0.04),质量调整生命年增加0.29(95%CI 0.08-0.49),EQ-VAS增加1.65(95%CI 0.56-2.72)。
  • 入院至穿刺时间每提前15分钟,5个领域各自及所有领域同时无或轻微问题的概率增加,范围从疼痛或不适的1.86%(95%CI 1.14-2.58)到所有领域同时的3.55%(95%CI 2.06-5.04)。
  • 入院至穿刺时间小于60分钟与各领域无或轻微问题几率更高相关,OR范围从疼痛或不适的1.49(95%CI 1.13-1.95)到活动能力的2.59(95%CI 1.83-3.68),需治疗人数范围为7至17。
  • 缺失数据多重插补后结果相似,评估从卒中发病时间时结果减弱。

临床怎么用

  • 作者认为,这些结果支持入院至治疗速度对患者报告结局的有益影响,并应鼓励通过优化院内流程和工作流程来改善以患者为中心的急性卒中照护。

局限性

  • 评估从卒中发病时间时结果减弱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The time-benefit association of endovascular thrombectomy (EVT) in ischemic stroke with patient-reported outcomes is unknown. OBJECTIVE: To assess the time-dependent association of EVT with self-reported quality of life in patients with acute ischemic stroke. DESIGN, SETTING, AND PARTICIPANTS: Data were used from the Safety and Efficacy of Nerinetide in Subjects Undergoing Endovascular Thrombectomy for Stroke (ESCAPE-NA1) trial, which tested the effect of nerinetide on functional outcomes in patients with large vessel occlusion undergoing EVT and enrolled patients from March 1, 2017, to August 12, 2019. The ESCAPE-NA1 trial was an international randomized clinical trial that recruited patients from 7 countries. Patients with EuroQol 5-dimension 5-level (EQ-5D-5L) index values at 90 days and survivors with complete domain scores were included in the current study. Data were analyzed from July to September 2023. EXPOSURE: Hospital arrival to arterial puncture time and other time metrics. MAIN OUTCOMES AND MEASURES: EQ-5D-5L index scores were calculated at 90 days using country-specific value sets. The association between time from hospital arrival to EVT arterial-access (door-to-puncture) and EQ-5D-5L index score, quality-adjusted life years, and visual analog scale (EQ-VAS) were evaluated using quantile regression, adjusting for age, sex, stroke severity, stroke imaging, wake-up stroke, alteplase, and nerinetide treatment and accounting for clustering by site. Using logistic regression, the association between door-to-puncture time and reporting no or slight symptoms (compared with moderate, severe, or extreme problems) was determined in each domain (mobility, self-care, usual activities, pain or discomfort, and anxiety or depression) or across all domains. Time from stroke onset was also evaluated, and missing data were imputed in sensitivity analyses. RESULTS: Among 1105 patients in the ESCAPE-NA1 trial, there were 1043 patients with EQ-5D-5L index values at 90 days, among whom 147 had died and were given a score of 0, and 1039 patients (mean [SD] age, 69.0 [13.7] years; 527 male [50.7%]) in the final analysis as 4 did not receive EVT. There were 896 survivors with complete domain scores at 90 days. There was a strong association between door-to-puncture time and EQ-5D-5L index score (increase of 0.03; 95% CI, 0.02-0.04 per 15 minutes of earlier treatment), quality-adjusted life years (increase of 0.29; 95% CI, 0.08-0.49 per 15 minutes of earlier treatment), and EQ-VAS (increase of 1.65; 95% CI, 0.56-2.72 per 15 minutes of earlier treatment). Each 15 minutes of faster door-to-puncture time was associated with higher probability of no or slight problems in each of 5 domains and all domains concurrently (range from 1.86%; 95% CI, 1.14-2.58 for pain or discomfort to 3.55%; 95% CI, 2.06-5.04 for all domains concurrently). Door-to-puncture time less than 60 minutes was associated higher odds of no or slight problems in each domain, ranging from odds ratios of 1.49 (95% CI, 1.13-1.95) for pain or discomfort to 2.59 (95% CI, 1.83-3.68) for mobility, with numbers needed to treat ranging from 7 to 17. Results were similar after multiple imputation of missing data and attenuated when evaluating time from stroke onset. CONCLUSIONS AND RELEVANCE: Results suggest that faster door-to-puncture EVT time was strongly associated with better health-related quality of life across all domains. These results support the beneficial impact of door-to-treatment speed on patient-reported outcomes and should encourage efforts to improve patient-centered care in acute stroke by optimizing in-hospital processes and workflows.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Joundi RA, Smith EE, Ganesh A, et al. Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke. JAMA Neurol. 2024. PMID: 38829660. doi:10.1001/jamaneurol.2024.1562

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。